TABLE 1

Demographics and Clinical Characteristics of the Study Infants

CharacteristicaAll Infants N = 7549Low-Risk N = 1121Non-Low-Risk N = 6428P
GA (completed weeks), median, IQR 37 (33–39) 34 (30–37) 38 (34–40) <.001 
GA category (completed weeks), n, % <.001 
 <28 462 (6.1) 113 (10.1) 349 (5.4) 
 28–30 540 (7.2) 170 (15.1) 370 (5.8) 
 31–33 938 (12.4) 232 (20.7) 706 (11.0) 
 34–36 1480 (19.6) 299 (26.7) 1181 (18.4) 
 ≥37 4123 (54.6) 307 (27.3) 3816 (59.4) 
BW (g), median, IQR 2859 (2000–3440) 2067 (1310–2910) 2970 (2160–3490) <.001 
BW category (g), n, % <.001 
 <1000 497 (6.6) 150 (13.4) 347 (5.4) 
 1000–1999 1379 (18.3) 382 (34.0) 997 (15.5) 
 2000–2999 2256 (29.9) 323 (28.8) 1933 (30.1) 
 ≥3000 3412 (45.2) 266 (23.7) 3146 (48.9) 
Female sex, n, % 3313 (43.9) 520 (46.4) 2793 (43.5) .068 
Maternal race/ethnicity, n, % <.001 
 African American 4136 (54.8) 548 (48.9) 3588 (55.8) 
 White 2186 (29.0) 438 (39.1) 1748 (27.2) 
 Hispanic 435 (5.8) 56 (5.0) 379 (5.9) 
 Other/unknown 792 (10.5) 79 (7.1) 713 (11.1) 
Maternal age (y), median, IQR 28 (22–33) 30 (25–35) 27 (22–32) <.001 
5-min Apgar score <5, n, % 331 (4.4) 65 (5.8) 266 (4.1) .004 
Length of stay (d), median, IQR 6 (3–18) 15 (5–40) 5 (3–15) <.001 
Early-onset sepsis, n, % 41 (0.54) 41 (0.64) .003 
Antibiotics in first 72 h, n, % 6754 (89.5) 901 (80.4) 5853 (91.1) <.001 
Antibiotic duration, hours, median, IQR 39 (37–59)b 47 (37–62)c 38 (37–51)d <.001 
Prolonged antibiotics, n, % 1241 (18.5)b 203 (22.5)c 1038 (17.9)d .001 
CharacteristicaAll Infants N = 7549Low-Risk N = 1121Non-Low-Risk N = 6428P
GA (completed weeks), median, IQR 37 (33–39) 34 (30–37) 38 (34–40) <.001 
GA category (completed weeks), n, % <.001 
 <28 462 (6.1) 113 (10.1) 349 (5.4) 
 28–30 540 (7.2) 170 (15.1) 370 (5.8) 
 31–33 938 (12.4) 232 (20.7) 706 (11.0) 
 34–36 1480 (19.6) 299 (26.7) 1181 (18.4) 
 ≥37 4123 (54.6) 307 (27.3) 3816 (59.4) 
BW (g), median, IQR 2859 (2000–3440) 2067 (1310–2910) 2970 (2160–3490) <.001 
BW category (g), n, % <.001 
 <1000 497 (6.6) 150 (13.4) 347 (5.4) 
 1000–1999 1379 (18.3) 382 (34.0) 997 (15.5) 
 2000–2999 2256 (29.9) 323 (28.8) 1933 (30.1) 
 ≥3000 3412 (45.2) 266 (23.7) 3146 (48.9) 
Female sex, n, % 3313 (43.9) 520 (46.4) 2793 (43.5) .068 
Maternal race/ethnicity, n, % <.001 
 African American 4136 (54.8) 548 (48.9) 3588 (55.8) 
 White 2186 (29.0) 438 (39.1) 1748 (27.2) 
 Hispanic 435 (5.8) 56 (5.0) 379 (5.9) 
 Other/unknown 792 (10.5) 79 (7.1) 713 (11.1) 
Maternal age (y), median, IQR 28 (22–33) 30 (25–35) 27 (22–32) <.001 
5-min Apgar score <5, n, % 331 (4.4) 65 (5.8) 266 (4.1) .004 
Length of stay (d), median, IQR 6 (3–18) 15 (5–40) 5 (3–15) <.001 
Early-onset sepsis, n, % 41 (0.54) 41 (0.64) .003 
Antibiotics in first 72 h, n, % 6754 (89.5) 901 (80.4) 5853 (91.1) <.001 
Antibiotic duration, hours, median, IQR 39 (37–59)b 47 (37–62)c 38 (37–51)d <.001 
Prolonged antibiotics, n, % 1241 (18.5)b 203 (22.5)c 1038 (17.9)d .001 

BW, birth weight; g, grams; GA, gestational age; IQR, interquartile range.

a

Missing data are present for the following characteristics: gestational age (n = 6), birth wt (n = 5), maternal age (n = 214), 5-min Apgar score (n = 74).

b

Denominator (6713) includes infants started on antibiotics in the first 72 h without EOS.

c

Denominator (901) includes infants started on antibiotics in the first 72 h without EOS.

d

Denominator (5812) includes infants started on antibiotics in the first 72 h without EOS.

Close Modal

or Create an Account

Close Modal
Close Modal